CREXENDO INC (CXDO) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CXDO SEC filings page.
CREXENDO INC (CXDO) reported $68.2M in revenue for fiscal year 2025, up 12.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Crexendo has moved from losses to cash-generating profitability while requiring little reinvestment and carrying a lightly leveraged balance sheet.
Cash conversion is unusually direct: in FY2025, net income was$5.1M while operating cash flow reached$9.3M and free cash flow was$9.3M . Because capital expenditures were only$18K , reported earnings are currently converting into cash without substantial reinvestment or a large working-capital drain.
From FY2022 through FY2025, revenue expanded from
Short-term financial flexibility has widened: the current ratio rose from 1.2x in FY2022 to 3.4x in FY2025, giving current assets substantially more room over near-term obligations. Total liabilities were
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of CREXENDO INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
CREXENDO INC held $31.4M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $9.3M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and CREXENDO INC scores 85/100 among other emerging companies.
CREXENDO INC had 31M shares outstanding at the end of fiscal year 2025, against 28M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and CREXENDO INC scores 50/100 among other emerging companies.
CREXENDO INC spent $5.7M on research and development in fiscal year 2025, which was 9.0% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and CREXENDO INC scores 34/100 among other emerging companies.
CREXENDO INC reported revenue of $68.2M in fiscal year 2025, against $60.8M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and CREXENDO INC scores 59/100 among other emerging companies.
Not available for CREXENDO INC, and counted as zero in the overall score.
CREXENDO INC's cash, cash equivalents and investments came to $31.4M at the end of fiscal year 2025, against $13.9M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and CREXENDO INC scores 77/100 among other emerging companies.
CREXENDO INC scores 7.93, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($181.9M) relative to total liabilities ($13.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
CREXENDO INC passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, CREXENDO INC generates $1.83 in operating cash flow ($9.3M OCF vs $5.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
CREXENDO INC earns $246.84 in operating income for every $1 of interest expense ($4.7M vs $19K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
CREXENDO INC generated $24.6M in revenue in Q2 2026. This represents an increase of 48.9% from the same quarter a year earlier. Against the prior quarter it is up 19.0%.
CREXENDO INC's EBITDA was $1.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 3.5% from the same quarter a year earlier. Against the prior quarter it is up 130.5%.
CREXENDO INC reported $1.1M in net income in Q2 2026. This represents a decrease of 14.7% from the same quarter a year earlier. Against the prior quarter it is up 81.8%.
CREXENDO INC earned $0.03 per diluted share (EPS) in Q2 2026. This represents a decrease of 25.0% from the same quarter a year earlier. Against the prior quarter it is up 50.0%.
Cash & Balance Sheet
CREXENDO INC held $18.3M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
CREXENDO INC's operating margin was 4.3% in Q2 2026, reflecting core business profitability. This is down 2.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.2 percentage points.
CREXENDO INC's net profit margin was 4.3% in Q2 2026, showing the share of revenue converted to profit. This is down 3.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.
CREXENDO INC's ROE was 1.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.
Not reported for Q2 2026.
Capital Allocation
CREXENDO INC invested $1.8M in research and development in Q2 2026. This represents an increase of 27.3% from the same quarter a year earlier. Against the prior quarter it is up 16.8%.
Not reported for Q2 2026.
Not reported for Q2 2026.
CXDO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.6M+48.9% | $20.7M+29.0% | $18.1M+11.2% | $17.5M+12.0% | $16.6M+12.7% | $16.1M+12.4% | $16.2M+14.7% | $15.6M+12.6% |
| R&D Expenses | $1.8M+27.3% | $1.6M+2.9% | $1.3M-10.4% | $1.4M-4.0% | $1.4M+8.2% | $1.5M+21.9% | $1.5M+19.7% | $1.5M+15.5% |
| SG&A Expenses | $5.3M+48.8% | $5.1M+43.7% | $3.8M+12.7% | $3.8M+2.3% | $3.6M+4.5% | $3.5M+6.8% | $3.4M | $3.7M+11.7% |
| Operating Income | $1.1M-4.4% | $440K-61.7% | $1.1M+80.8% | $1.3M+866.7% | $1.1M+90.2% | $1.1M+138.1% | $626K+1547.4% | $135K-62.9% |
| EBITDA | $1.1M-3.5% | $485K-60.1% | $1.2M+68.6% | $1.4M+550.2% | $1.2M+76.0% | $1.2M+115.8% | $697K+462.1% | $209K-54.4% |
| Interest Expense | -$62K | $0 | N/A | $0-100.0% | $0-100.0% | $0-100.0% | N/A | $7K-80.6% |
| Income Tax | $25K-47.9% | $29K-34.1% | N/A | $43K-6.5% | $48K+77.8% | $44K+63.0% | N/A | $46K+39.4% |
| Net Income | $1.1M-14.7% | $578K-50.6% | $1.2M+140.2% | $1.4M+879.7% | $1.2M+109.5% | $1.2M+169.8% | $507K+731.1% | $148K-91.3% |
| EPS (Basic) | $0.03-25.0% | $0.02-50.0% | $0.04+100.0% | $0.05+400.0% | $0.04+100.0% | $0.04+100.0% | $0.02 | $0.01-85.7% |
| EPS (Diluted) | $0.03-25.0% | $0.02-50.0% | $0.04+100.0% | $0.05 | $0.04+100.0% | $0.04+300.0% | $0.02 | $0.00-100.0% |
| Diluted Shares (Avg) | 34M+9.3% | 33M+5.1% | N/A | 32M+6.6% | 31M+6.1% | 31M+3.2% | N/A | 30M+7.9% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit.
CXDO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $101.0M+41.6% | $91.3M+35.3% | $77.7M+19.6% | $76.0M+22.0% | $71.4M+19.7% | $67.4M+17.4% | $64.9M+15.6% | $62.3M+12.5% |
| Current Assets | $34.8M+0.5% | $23.0M-23.6% | $41.9M+55.9% | $39.3M+64.7% | $34.6M+58.2% | $30.1M+58.3% | $26.9M+58.6% | $23.9M+52.8% |
| Cash & Equivalents | $18.3M-22.0% | $7.2M-65.8% | $31.4M+72.5% | $28.6M+84.9% | $23.4M+72.3% | $21.2M+92.1% | $18.2M+75.8% | $15.5M+99.7% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $1.4M+123.3% | $1.2M+103.1% | $454K+15.5% | $640K+23.6% | $618K+11.6% | $576K+51.2% | $393K+2.9% | $518K+9.7% |
| Accounts Receivable | $6.2M+10.1% | $6.4M+57.0% | $4.9M+12.9% | $4.7M+26.5% | $5.6M+40.8% | $4.1M-3.7% | $4.4M+25.2% | $3.8M-3.1% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $14.2M+49.9% | $2K-100.0% | $9.5M0.0% | $9.5M0.0% | $9.5M0.0% | $9.5M0.0% | $9.5M0.0% | $9.5M0.0% |
| Total Liabilities | $22.9M+75.5% | $18.6M+51.9% | $13.9M+2.5% | $14.6M+14.3% | $13.1M+14.1% | $12.2M+14.2% | $13.5M+17.1% | $12.8M+9.7% |
| Current Liabilities | $16.9M+39.8% | $16.8M+51.0% | $12.3M+1.9% | $13.6M+22.0% | $12.1M+15.9% | $11.1M+15.6% | $12.1M+17.9% | $11.2M+10.4% |
| Non-Current Liabilities | $6.0M+524.7% | $1.8M+60.5% | $1.5M+7.4% | $1.0M-37.9% | $962K-4.8% | $1.1M+1.9% | $1.4M+11.3% | $1.6M+5.2% |
| Long-Term Debt | N/A | N/A | $114K-80.7% | $236K-66.7% | $356K-56.7% | $475K-49.3% | $592K | $709K-38.9% |
| Total Equity | $78.1M+34.0% | $72.7M+31.7% | $63.8M+24.1% | $61.3M+24.0% | $58.3M+21.0% | $55.2M+18.1% | $51.4M+15.2% | $49.5M+13.2% |
| Retained Earnings | -$80.1M+5.1% | -$81.1M+5.2% | -$81.7M+5.8% | -$82.9M+5.0% | -$84.4M+3.5% | -$85.6M+2.7% | -$86.8M+1.9% | -$87.3M+1.4% |
CXDO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.8M+112.4% | $2.0M+64.5% | $2.3M+7.8% | $4.4M+172.5% | $1.3M-51.2% | $1.2M+845.8% | $2.2M-16.7% | $1.6M+3.9% |
| Depreciation & Amortization | $63K+14.5% | $45K-30.8% | $43K-39.4% | $54K-27.0% | $55K-29.5% | $65K-18.8% | $71K-17.4% | $74K-21.3% |
| Stock-Based Compensation | N/A | $721K-0.7% | N/A | $766K-1.9% | $762K-2.8% | $726K-0.3% | N/A | $781K-7.4% |
| Capital Expenditures | N/A | N/A | $0-100.0% | $0 | $18K | $0 | $27K | $0-100.0% |
| Free Cash Flow | N/A | N/A | $2.3M+9.2% | $4.4M+172.5% | $1.3M-51.8% | $1.2M+845.8% | $2.1M-17.7% | $1.6M+1505.0% |
| Investing Cash Flow | $1K+105.6% | -$26.2M | $0+100.0% | $0 | -$18K | $0 | -$27K | $0-100.0% |
| Financing Cash Flow | $8.3M+788.0% | $61K-96.5% | $461K-21.1% | $725K+211.2% | $933K+1251.9% | $1.8M+105.2% | $584K+3144.4% | $233K+112.7% |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0 |
Not reported in any period shown, so not listed: Share Buybacks.
CXDO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.3%-2.4pp | 2.1%-5.0pp | 6.3%+2.4pp | 7.5%+6.6pp | 6.7%+2.7pp | 7.2%+3.8pp | 3.9%+3.6pp | 0.9%-1.8pp |
| Net Margin | 4.3%-3.2pp | 2.8%-4.5pp | 6.7%+3.6pp | 8.3%+7.3pp | 7.4%+3.4pp | 7.3%+4.3pp | 3.1%+2.7pp | 0.9%-11.3pp |
| Return on Equity | 1.4%-0.8pp | 0.8%-1.3pp | 1.9%+0.9pp | 2.4%+2.1pp | 2.1%+0.9pp | 2.1%+1.2pp | 1.0%+0.9pp | 0.3%-3.6pp |
| Return on Assets | 1.0%-0.7pp | 0.6%-1.1pp | 1.6%+0.8pp | 1.9%+1.7pp | 1.7%+0.7pp | 1.7%+1.0pp | 0.8%+0.7pp | 0.2%-2.8pp |
| Current Ratio | 2.06-0.8x | 1.37-1.3x | 3.40+1.2x | 2.89+0.8x | 2.86+0.8x | 2.71+0.7x | 2.22+0.6x | 2.14+0.6x |
| Debt-to-Equity | 0.29+0.3x | 0.26+0.2x | 0.000.0x | 0.000.0x | 0.010.0x | 0.010.0x | 0.01-0.2x | 0.010.0x |
| Asset Turnover | 0.240.0x | 0.230.0x | 0.230.0x | 0.230.0x | 0.230.0x | 0.240.0x | 0.250.0x | 0.250.0x |
| FCF Margin | N/A | N/A | 13.0%-0.3pp | 25.2%+14.9pp | 7.7%-10.3pp | 7.7%+8.9pp | 13.2%-5.2pp | 10.4%+9.6pp |
Not reported in any period shown, so not listed: Gross Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| CREXENDO INC CXDO | FY2025 | $68.2M | $5.1M | 7.4% | $181.9M | 51/100 |
| Radcom Ltd. RDCM | FY2025 | $71.5M | $12.0M | 16.8% | $168.7M | 67/100 |
| ATN International, Inc ATNI | FY2025 | $728.0M | -$23.5M | -3.2% | $396.6M | 29/100 |
| KVH Industries Inc KVHI | FY2025 | $111.0M | -$7.4M | -6.7% | $107.4M | 49/100 |
| FingerMotion, Inc. FNGR | FY2026 | $24.1M | -$7.0M | -29.2% | $12.9M | 26/100 |
| uCloudlink Group Inc. UCL | FY2025 | $81.4M | $6.3M | 7.7% | $9.1M | 54/100 |
Where CREXENDO INC Ranks
Frequently Asked Questions
What is CREXENDO INC's annual revenue?
CREXENDO INC (CXDO) reported $68.2M in total revenue for fiscal year 2025. This represents a 12.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is CREXENDO INC's revenue growing?
CREXENDO INC (CXDO) revenue grew by 12.0% year-over-year, from $60.8M to $68.2M in fiscal year 2025.
Is CREXENDO INC profitable?
Yes, CREXENDO INC (CXDO) reported a net income of $5.1M in fiscal year 2025, with a net profit margin of 7.4%.
What is CREXENDO INC's EBITDA?
CREXENDO INC (CXDO) had EBITDA of $4.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does CREXENDO INC have?
As of fiscal year 2025, CREXENDO INC (CXDO) had $31.4M in cash and equivalents against $114K in long-term debt.
What is CREXENDO INC's operating margin?
CREXENDO INC (CXDO) had an operating margin of 6.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is CREXENDO INC's net profit margin?
CREXENDO INC (CXDO) had a net profit margin of 7.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is CREXENDO INC's return on equity (ROE)?
CREXENDO INC (CXDO) has a return on equity of 8.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is CREXENDO INC's free cash flow?
CREXENDO INC (CXDO) generated $9.3M in free cash flow during fiscal year 2025. This represents a 48.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is CREXENDO INC's operating cash flow?
CREXENDO INC (CXDO) generated $9.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are CREXENDO INC's total assets?
CREXENDO INC (CXDO) had $77.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are CREXENDO INC's capital expenditures?
CREXENDO INC (CXDO) invested $18K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does CREXENDO INC spend on research and development?
CREXENDO INC (CXDO) invested $5.7M in research and development during fiscal year 2025.
What is CREXENDO INC's current ratio?
CREXENDO INC (CXDO) had a current ratio of 3.40 as of fiscal year 2025, which is generally considered healthy.
What is CREXENDO INC's debt-to-equity ratio?
CREXENDO INC (CXDO) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is CREXENDO INC's return on assets (ROA)?
CREXENDO INC (CXDO) had a return on assets of 6.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is CREXENDO INC's P/E ratio?
CREXENDO INC (CXDO) trades at 42.3x earnings, its market capitalization divided by net income of $4.3M net income, trailing 12 months to June 30, 2026. The market capitalization is $181.9M as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is CREXENDO INC's price-to-sales ratio?
CREXENDO INC (CXDO) trades at 2.2x sales, its market capitalization divided by revenue of $80.9M revenue, trailing 12 months to June 30, 2026. The market capitalization is $181.9M as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is CREXENDO INC's Altman Z-Score?
CREXENDO INC (CXDO) has an Altman Z-Score of 7.93, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is CREXENDO INC's Piotroski F-Score?
CREXENDO INC (CXDO) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are CREXENDO INC's earnings high quality?
CREXENDO INC (CXDO) has an earnings quality ratio of 1.83x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can CREXENDO INC cover its interest payments?
CREXENDO INC (CXDO) has an interest coverage ratio of 246.84x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is CREXENDO INC?
CREXENDO INC (CXDO) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.